Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-75,024
Closed -$3.95M 683
2025
Q2
$3.95M Buy
75,024
+10,080
+16% +$474K 0.01% 613
2025
Q1
$2.73M Buy
+64,944
New +$2.83M 0.01% 678
2022
Q4
Sell
-266,477
Closed -$5.34M 1190
2022
Q3
$5.34M Buy
266,477
+43,511
+20% +$1.04M 0.02% 563
2022
Q2
$5.05M Sell
222,966
-4,334
-2% -$90.5K 0.02% 580
2022
Q1
$6.01M Sell
227,300
-49,971
-18% -$1.34M 0.02% 598
2021
Q4
$8.82M Buy
277,271
+3,204
+1% +$90.5K 0.02% 532
2021
Q3
$6.03M Buy
274,067
+10,095
+4% +$216K 0.02% 636
2021
Q2
$5.56M Buy
+263,972
New +$5.84M 0.02% 679

Other funds holding MRUS

Axa's MRUS Position: Q3 2025 in Review

Axa sold out of Merus (MRUS) in Q3 2025, closing a stake of 75,024 shares — an estimated $3.95M sold.

Axa first reported a position in MRUS in Q2 2021 and held it in 8 quarters. The position peaked at $8.82M in Q4 2021. 268 funds tracked by Wall St. Rank hold MRUS as of Q3 2025.

  • Axa reported no remaining Merus position as of Q3 2025 after selling out during the quarter.
  • Axa sold 75,024 Merus shares in Q3 2025, an estimated $3.95M.
  • Axa first reported a position in Merus in Q2 2021 and held it in 8 quarters.
  • Axa's Merus position peaked at $8.82M in Q4 2021.
  • 268 funds tracked by Wall St. Rank held Merus as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.